332 related articles for article (PubMed ID: 16551628)
1. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells.
Reddy MA; Li SL; Sahar S; Kim YS; Xu ZG; Lanting L; Natarajan R
J Biol Chem; 2006 May; 281(19):13685-13693. PubMed ID: 16551628
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line.
Hayakawa E; Yoshimoto T; Sekizawa N; Sugiyama T; Hirata Y
J Atheroscler Thromb; 2012; 19(1):13-22. PubMed ID: 22082983
[TBL] [Abstract][Full Text] [Related]
3. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes.
Figarola JL; Shanmugam N; Natarajan R; Rahbar S
Diabetes; 2007 Mar; 56(3):647-55. PubMed ID: 17327432
[TBL] [Abstract][Full Text] [Related]
5. S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2.
Shaw SS; Schmidt AM; Banes AK; Wang X; Stern DM; Marrero MB
Diabetes; 2003 Sep; 52(9):2381-8. PubMed ID: 12941779
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products.
Shanmugam N; Kim YS; Lanting L; Natarajan R
J Biol Chem; 2003 Sep; 278(37):34834-44. PubMed ID: 12837757
[TBL] [Abstract][Full Text] [Related]
7. 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling.
Singh NK; Wang D; Kundumani-Sridharan V; Van Quyen D; Niu J; Rao GN
J Biol Chem; 2011 Jun; 286(25):22478-88. PubMed ID: 21536676
[TBL] [Abstract][Full Text] [Related]
8. Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation.
Meng L; Park J; Cai Q; Lanting L; Reddy MA; Natarajan R
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H736-45. PubMed ID: 20008269
[TBL] [Abstract][Full Text] [Related]
9. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release.
Bianchi R; Kastrisianaki E; Giambanco I; Donato R
J Biol Chem; 2011 Mar; 286(9):7214-26. PubMed ID: 21209080
[TBL] [Abstract][Full Text] [Related]
10. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells.
Reddy MA; Sahar S; Villeneuve LM; Lanting L; Natarajan R
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):387-93. PubMed ID: 19095999
[TBL] [Abstract][Full Text] [Related]
11. RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes.
Perrone L; Peluso G; Melone MA
J Cell Physiol; 2008 Oct; 217(1):60-71. PubMed ID: 18452184
[TBL] [Abstract][Full Text] [Related]
12. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction.
Tsoporis JN; Izhar S; Leong-Poi H; Desjardins JF; Huttunen HJ; Parker TG
Circ Res; 2010 Jan; 106(1):93-101. PubMed ID: 19910580
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes.
Rasheed Z; Akhtar N; Haqqi TM
Rheumatology (Oxford); 2011 May; 50(5):838-51. PubMed ID: 21172926
[TBL] [Abstract][Full Text] [Related]
14. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner.
Sorci G; Riuzzi F; Agneletti AL; Marchetti C; Donato R
Mol Cell Biol; 2003 Jul; 23(14):4870-81. PubMed ID: 12832473
[TBL] [Abstract][Full Text] [Related]
15. Ligation of RAGE with ligand S100B attenuates ABCA1 expression in monocytes.
Kumar P; Raghavan S; Shanmugam G; Shanmugam N
Metabolism; 2013 Aug; 62(8):1149-58. PubMed ID: 23523156
[TBL] [Abstract][Full Text] [Related]
16. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding.
Sorci G; Riuzzi F; Arcuri C; Giambanco I; Donato R
Mol Cell Biol; 2004 Jun; 24(11):4880-94. PubMed ID: 15143181
[TBL] [Abstract][Full Text] [Related]
17. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts).
Hattori Y; Suzuki M; Hattori S; Kasai K
Hypertension; 2002 Jan; 39(1):22-8. PubMed ID: 11799073
[TBL] [Abstract][Full Text] [Related]
18. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis.
Loeser RF; Yammani RR; Carlson CS; Chen H; Cole A; Im HJ; Bursch LS; Yan SD
Arthritis Rheum; 2005 Aug; 52(8):2376-85. PubMed ID: 16052547
[TBL] [Abstract][Full Text] [Related]
19. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
20. RAGE mediates β-catenin stabilization via activation of the Src/p-Cav-1 axis in a chemical-induced asthma model.
Zhao W; Lin Y; Xiong J; Wang Y; Huang G; Deng Q; Yao L; Yu C; Dong H; Cai S; Zhao H
Toxicol Lett; 2018 Dec; 299():149-158. PubMed ID: 30261222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
